You tried Wegovy and plateaued
Weight loss is about more than medication, or even the number on the scale
Report any persistent neck lump, hoarseness lasting more than two weeks, difficulty swallowing, unexplained shortness of breath, or persistent cough to your GP promptly for investigation
Tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is therefore not recommended in these patients
Even before today's FDA announcement, Dr
For tirzepatide, clinics should rely on current FDA labeling for: Contraindications Warnings and precautions Use in pregnancy Drug interactions Guidance for patients with certain endocrine histories or GI conditions Monitoring recommendations For AOD 9604, the lack of FDA approved labeling for obesity means clinics have less standardized, label grounded safety direction for that use